Nath Bio-Genes (India) Limited — Investor Meet, 02-05-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Nath Bio-Genes has announced a conference call following the financial results for the quarter and half-year. The company saw strong growth in its non-cotton, non-paddy segment, now 48% of revenue, led by Bajra’s Super-27 and gains in maize, wheat, and vegetables. FY25 revenue reached INR362.3 Cr, with gross margin steady above 52%, EBITDA up 4%, and PAT rising 13.3%. Advanced bookings surged 63% YoY to INR150 Cr. Focus remains on R&D (~4-5% of sales) and diversification, with promising international expansion in Uzbekistan and ongoing trials in the Philippines. Management targets 15% revenue growth and sustained margins around 52-54%, aiming for INR500 Cr sales in 2 years. Cotton leadership continues via differentiated hybrids despite pricing controls. Cash is mostly operational, linked to advance payments. The outlook is confident on growth, innovation, and market expansion.